Seminars in Thrombosis and Hemostasis

Papers
(The TQCC of Seminars in Thrombosis and Hemostasis is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
92
59
The Next, Next-Generation of Sequencing, Promising to Boost Research and Clinical Practice56
Thrombotic Antiphospholipid Syndrome and Direct Oral Anticoagulants: Unmet Needs and Review of the Literature51
Drug–Drug Interactions in the Treatment of Cancer-Associated Venous Thromboembolism with Direct Oral Anticoagulants43
Prevention of Venous Thromboembolism in Medical Patients with Thrombocytopenia or with Platelet Dysfunction: The Last 10 Years42
Hemostatic Manifestations of Invasive Fungal Infections: A Comprehensive Review of Pathophysiological Mechanisms in Sepsis-Induced Hemostatic Disturbances, with a Focus on the Neonatal Population39
Role of Platelets in Rheumatic Chronic Autoimmune Inflammatory Diseases37
Fright of Long-Haul Flights: Focus on Travel-Associated Thrombosis35
Cancer-Associated Thrombosis: Implications toward Health-Related Quality of Life35
Thrombosis in Antiphospholipid Syndrome: Current Perspectives and Challenges in Laboratory Testing for Antiphospholipid Antibodies34
Redefining Fibrinolytic Insufficiency in Sepsis-Associated DIC34
Monitoring Hemostatic Function During Extracorporeal Membrane Oxygenation with Point-of-Care Viscoelastic Assays: A Narrative Review34
Resonant Acoustic Rheometry to Measure Coagulation Kinetics in Hemophilia A and Healthy Plasma: A Novel Viscoelastic Method32
Testing for Lupus Anticoagulants31
Thrombin Generation Assays in Clinical Hemostasis: From Mechanistic Insights to Clinical Applications30
Application of ACR/EULAR Classification Criteria in Real Life: Thrombotic Patients Positive for Lupus Anticoagulant Only26
Lupus Anticoagulant-hypoprothrombinemia Syndrome: A Review Enriched by a New Particular Patient26
Platelet Function Testing: Update and Future Directions26
Platelet Activation and Thrombosis in COVID-1926
Gut Microbiota and Venous Thromboembolism: An Emerging Link25
Anticoagulation Management of Patients with Antiphospholipid Syndrome Undergoing Cardiopulmonary Bypass in Cardiac Surgery: Challenges and Current Strategies24
Editorial Compilation—XIII24
Platelet Function: Acute versus Chronic Responses to Physical Exercise: A Review24
The History of Rare Bleeding Disorders23
Evolving Knowledge on Primary and Secondary Prevention of Venous Thromboembolism in Carriers of Hereditary Thrombophilia: A Narrative Review22
External Quality Assessment for Unfractionated Heparin Monitoring: An Update from Australasia/Asia-Pacific22
How Do Laboratories Perform von Willebrand Disease Diagnostics and Classification of von Willebrand Disease Patients? Results from External Quality Data and an International Survey22
22
Anti-platelet Factor 4 Antibody-Mediated Disorders: An Updated Narrative Review21
Autoantibodies in Autoimmune Coagulation Factor Deficiencies: A Review of Inhibitory and Clearance-Accelerating Mechanisms from Japanese Practice21
Modulating Immune Responses: The Double-Edged Sword of Platelet CD40L20
Toward 50 Years of Seminars in Thrombosis and Hemostasis19
Evolution of Clinical Trials in Anticoagulation for Sepsis: Bridging Past to Future19
Fifty Years of Fibrinogen Structure and Function19
Gene Therapy for Hemophilia B: Achievements, Open Issues, and Perspectives19
Patterns of Antiphospholipid Antibody Testing and Positivity in a Real-World Laboratory over Two Decades: The Role of IgM18
Bleeding in Patients with Renal Impairment: A Current Perspective18
Celebrating 50 Years of Seminars in Thrombosis and Hemostasis—Part III18
2022 Eberhard F. Mammen Award Announcements: Part I—Most Popular Articles18
Association between Severe Acute Respiratory Syndrome Coronavirus 2 Infection (Coronavirus Disease 2019) and Lupus Anticoagulant-Hypoprothrombinemia Syndrome: A Case Report and Literature Assessment18
Magnetic Resonance Screening for Cerebral Venous Sinus Thrombosis during Treatment with Pegaspargase18
Platelet Function in Patients with Disseminated Intravascular Coagulation: Potential Markers for Improving DIC Diagnosis?17
50 Years of Pediatric Hemostasis: Knowledge, Diagnosis, and Treatment17
Comprehensive Mendelian Randomization Analysis of Smoking and Its Effects on Venous Thromboembolism16
Platelet–Red Blood Cell Interactions in Thrombosis: Integrating Hemodynamic, Molecular, and Clinical Evidence–A Systematic Review16
Investigating a Signal of Acquired Hemophilia Associated with COVID-19 Vaccination: A Systematic Case Review16
Bernard–Soulier Syndrome: A Review of Epidemiology, Molecular Pathology, Clinical Features, Laboratory Diagnosis, and Therapeutic Management15
15
15
Strength of Anticoagulation in Moderate to Severe COVID-19 Illness: In Medio Stat Virtus?14
2025 Eberhard F. Mammen Award Announcements–Part II: Young Investigator Awards14
Automation in Platelet Function Testing: Current Challenges and Future Directions14
Machine Learning Prediction of Stress-Induced D-dimer Reactivity in Male Physicians with and without Burnout14
Emicizumab in Type 3 von Willebrand Disease: Report of a Case with an Alloantibody and Literature Review14
Seminars in Thrombosis and Hemostasis: 2024 Impact Factor, Most Highly Cited Papers, and Other Journal Metrics14
External Quality Assessment Data for Investigation of von Willebrand Disease: Focus on Relative Utility of Contemporary Functional von Willebrand Factor Assays. The United Kingdom National External Qu14
Mendelian Randomization Provides No Evidence for the Bidirectional Relationship between Type 2 Diabetes and Venous Thromboembolism in East Asians and African Americans14
In Search of the Perfect Thrombosis and Bleeding-Associated Cancer Scale14
Reply to the Comment: Research Design Concerns in a TriNetX Analysis of Venous Thromboembolism in Pediatric Cystic Fibrosis Patients14
Laboratory Testing for the Evaluation of Phenotypic Activated Protein C Resistance14
Use of Present-on-Admission Indicators to Improve Accuracy of Pulmonary Embolism Identification from Electronic Health Record Data14
From Ink Pens to Computers: A Personal Look Back at Landmark Changes during 5 Decades as a Clinical Laboratory Scientist in U.S. Hemostasis Laboratories14
Gene Therapy in Hemophilia A: Achievements, Challenges, and Perspectives13
13
Physical Activity in People with Hemophilia13
Neutrophil Extracellular Traps: At the Interface of Thrombosis and Comorbidities13
Comparative Study of Venous Thromboembolic Prophylaxis Strategies for Patients with Ischemic Stroke: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials13
Heparin-Like Anticoagulant: First Case Described in a Metastatic Biliopancreatic Cancer13
A Brief History of Hemostasis and Thrombosis at the Mayo Clinic13
Optimizing Venous Stenting: Consensus Recommendations for Enhanced Management of Lower Extremity Deep Vein Thrombosis13
The Erythrocyte–ROS Axis in Thrombosis and Hemostasis13
Colchicine as a Modulator of Platelet Function: A Systematic Review13
Clinical, Laboratory, and Molecular Aspects of Factor V Deficiency13
Lipopolysaccharide and Coagulation Factor XII: Biophysics of Contact Activation in Infection12
Red Blood Cell Biomechanics and Cancer-Associated Thrombosis12
Comparison of Platelet Function Tests for Long-Term Cardiovascular Events after Percutaneous Coronary Interventions12
Venous Thromboembolism in Children: The Rivaroxaban Experience12
Dosing Intensity of Anticoagulants for the Prevention and Treatment of Venous Thromboembolism and the Prevention of Stroke in Atrial Fibrillation: Why is There a Difference?12
Editorial Compilation XIV12
International Council for Standardization in Haematology Guidance for New Lot Verification of Coagulation Reagents, Calibrators, and Controls12
COVID-19 Vaccine-Associated Immune Thrombosis and Thrombocytopenia (VITT): Diagnostic Discrepancies and Global Implications12
Risk Factors for Left Ventricular Thrombus Formation in Patients with Dilated Cardiomyopathy11
Past, Present, and Future Perspectives of Plasminogen Activator Inhibitor 1 (PAI-1)11
Clinical Features of Antiphospholipid Syndrome with Intracardiac Mass11
Mortality from Pulmonary Embolism in Patients with Post-Coronavirus Disease Syndrome11
A Historical Perspective on the Reversal of Anticoagulants11
Emicizumab in Acquired Hemophilia A: A Real-World Case Series with Patient-Level Outcome Analysis11
11
COVID-19 and Anticoagulant Use: Did the Pandemic Push DOACs Ahead of Warfarin?11
Acquired Hemostasis Disorders11
Editorial Compilation—Part XVIII11
Decoding Clot Waveform Analysis: Toward Better Understanding and Harmonization11
Pleiotropic Effects of Heparin and its Monitoring in the Clinical Practice11
Impact of Hematocrit on Coagulation Measured by Rotational Thromboelastometry in Healthy Subjects and Patients with Polycythemia11
Pulmonary Embolism-Related Mortality in Femur Fracture Patients: A Recent Retrospective Epidemiological Analysis11
Bleeding Scoring Systems in Neonates: A Systematic Review11
Precision Medicine in Rare Bleeding Disorders10
Hematohidrosis in 15th Century Renaissance Art and a Review of Modern Literature10
Platelet Physiology10
100 Years of von Willebrand Disease: The Journey to Contemporary Diagnostic Pathways—An Illustrative Case-Based Narrative Review10
The Applicability of Thromboelastography in Acute Ischemic Stroke: A Literature Review10
Activated Partial Thromboplastin Time and Prothrombin Time Mixing Studies: Current State of the Art10
Evaluating Diagnostic Algorithms for Heparin-Induced Thrombocytopenia using Two Combined Automated Rapid Immunoassays10
D-Dimer Reporting and Harmonization: Analysis of College of American Pathologists D-Dimer Proficiency Testing Program10
Cancer-Associated Thrombosis and Beyond: Biomarkers, Treatments, and Cancer-Hemostasis Interactions9
Safety and Efficacy of Therapeutic Anticoagulation with Subcutaneous Unfractionated Heparin in Patients with Renal Failure9
Transitioning of Patients from Direct-Acting Oral Anticoagulant to Heparin: Impact on Laboratory Testing9
National Early Warning Score-2 for Identification of Patients with Intermediate-High-Risk Pulmonary Embolism9
Heterogeneity Among Plasma-Derived von Willebrand Factor Concentrates: Implications for Comparative Effectiveness Analyses9
Emerging Use of Viscoelastography in Thrombosis and Hemostasis: A Challenge to Conventional Coagulation Tests? Part I: The Use of Thromboelastography and Thromboelastometry in the Assessment of Hemost9
Thrombin Generation Assays: What are the Current Clinical Applications?9
The Pathophysiological Role of Platelet-Derived Extracellular Vesicles9
9
NETosis in Acute Thrombotic Disorders9
Current Diagnosis of von Willebrand Disease in Italy: 3 Years Following the Release of the International Guidelines9
Non-factor Therapies for Hemophilia: Achievements and Perspectives9
9
Do we Have the Gut to Beat Thrombosis?9
A Perspective on How Fibrinaloid Microclots and Platelet Pathology May be Applied in Clinical Investigations9
Hemostasis Testing in the Emergency Department: A Narrative Review9
Use of Plasma-Derived FVII Concentrate in Surgical Patients with Factor VII Deficiency: A Case Series9
Von Willebrand Disease Type 2A: An Update9
Molecular Mimicry between hPF4 and SARS-CoV-2 Spike Protein: Response to Comment9
The Role of Platelets in Atherosclerosis: A Historical Review9
Discordant High Activated Partial Thromboplastin Time Relative to Anti-Xa Values in Hospitalized Patients is an Independent Risk Factor for Increased 30-day Mortality8
2022 Eberhard F. Mammen Award Announcements: Part II—Young Investigator Awards8
PFA-100 System: A New Method for Assessment of Platelet Dysfunction8
Current Understandings on Biological Characteristics of Thrombolytics in Acute Ischemic Stroke8
Evolution of Antiphospholipid Syndrome8
Internal Quality Control in Hemostasis Assays8
Increased HDL-C Values and Mortality: Revolutionizing a Historical Paradigm?8
Advances in the Management of Coagulopathy in Trauma: The Role of Viscoelastic Hemostatic Assays across All Phases of Trauma Care8
Crucial Stepping Stones in Platelet History8
Laboratory Testing for Fibrinogen Disorders: From Routine Investigations to Research Studies8
The More Recent History of Hemophilia Treatment8
Laboratory Testing for ADAMTS13 for Thrombotic Thrombocytopenia Purpura and Beyond8
Why Does Rivaroxaban Not Work in Severe Mitral Stenosis?8
It Is Proposed That Cardiovascular Functions are Regulated by the Status of Ecto-phosphoproteins Orchestrated by Platelets8
0.51662802696228